HCA Healthcare, Inc. $HCA Shares Sold by Foster & Motley Inc.

Foster & Motley Inc. lowered its stake in HCA Healthcare, Inc. (NYSE:HCA) by 9.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,731 shares of the company’s stock after selling 2,925 shares during the period. HCA Healthcare comprises 0.7% of Foster & Motley Inc.’s investment portfolio, making the stock its 28th biggest position. Foster & Motley Inc.’s holdings in HCA Healthcare were worth $13,880,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Palisade Asset Management LLC purchased a new position in HCA Healthcare during the 3rd quarter worth $26,000. Holos Integrated Wealth LLC purchased a new position in HCA Healthcare in the fourth quarter valued at about $29,000. Aventura Private Wealth LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth $34,000. Harbor Capital Advisors Inc. grew its stake in HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after acquiring an additional 34 shares during the last quarter. Finally, JPL Wealth Management LLC purchased a new stake in shares of HCA Healthcare in the third quarter valued at about $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the transaction, the senior vice president directly owned 44,379 shares in the company, valued at $22,411,395. The trade was a 8.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael R. Mcalevey sold 1,694 shares of the firm’s stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the transaction, the executive vice president directly owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 15,214 shares of company stock valued at $7,797,595. Corporate insiders own 1.50% of the company’s stock.

HCA Healthcare Stock Performance

HCA stock opened at $467.70 on Tuesday. The stock has a market cap of $104.56 billion, a P/E ratio of 16.48, a P/E/G ratio of 1.45 and a beta of 1.34. HCA Healthcare, Inc. has a 52 week low of $314.43 and a 52 week high of $556.52. The firm has a 50 day simple moving average of $510.66 and a 200 day simple moving average of $477.00.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.99%.

Wall Street Analysts Forecast Growth

HCA has been the topic of several recent analyst reports. Argus upped their price objective on shares of HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a research note on Friday, February 6th. KeyCorp set a $503.00 target price on shares of HCA Healthcare in a report on Wednesday, January 28th. Morgan Stanley cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective for the company. in a research report on Monday, December 15th. Sanford C. Bernstein set a $541.00 price target on shares of HCA Healthcare in a research report on Monday, February 9th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a report on Friday. Sixteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $537.73.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.